首页 | 本学科首页   官方微博 | 高级检索  
     

胸腺上皮肿瘤WHO分型与系统性免疫炎症指数的相关性
引用本文:刘勇,赵亮,徐家行,付珺,赵轲,陈宝钧. 胸腺上皮肿瘤WHO分型与系统性免疫炎症指数的相关性[J]. 中华胸部外科电子杂志, 2020, 7(1): 17-21. DOI: 10.3877/cma.j.issn.2095-8773.2020.01.003
作者姓名:刘勇  赵亮  徐家行  付珺  赵轲  陈宝钧
作者单位:1. 430014 华中科技大学同济医学院附属武汉中心医院胸外科
摘    要:目的探讨胸腺上皮肿瘤的WHO组织学分型与系统性免疫炎症指数的相关性。 方法收集2017年1月至2019年12月经手术后病理学检查证实的胸腺上皮肿瘤患者的临床资料。根据WHO(2015版)胸腺上皮性肿瘤分型,将纳入研究的患者分为低危组、高危组和胸腺癌组;以同期接受手术治疗的胸腺良性肿物患者作为对照。所有患者于术前4 d内获取外周血内血小板、中性粒细胞、淋巴细胞计数,计算系统性免疫炎症指数。比较各组间系统性免疫炎症指数的差异,并分析其与肿瘤恶性程度的相关性。 结果共纳入胸腺上皮性肿瘤患者46例(低危组20例,高危组19例,胸腺癌组7例)和对照组患者34例。胸腺癌组系统性免疫炎症指数显著高于其余三组(P=0.009)。系统性免疫炎症指数与胸腺上皮性肿瘤的恶性程度显著相关(r=0.244,P=0.032)。 结论系统性免疫炎症指数与基于WHO分型的胸腺上皮性肿瘤恶性程度具有显著相关性,可作为胸腺上皮肿瘤恶性程度的临床预测指标。

关 键 词:胸腺上皮性肿瘤  WHO组织学分型  系统性免疫炎症指数  
收稿时间:2020-01-06

Correlation between thymic epithelial tumors and systemic immune-inflammation index based on WHO classification
Liu Yong,Zhao Liang,Xu Jiahang,Fu Jun,Zhao Ke,Chen Baojun. Correlation between thymic epithelial tumors and systemic immune-inflammation index based on WHO classification[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2020, 7(1): 17-21. DOI: 10.3877/cma.j.issn.2095-8773.2020.01.003
Authors:Liu Yong  Zhao Liang  Xu Jiahang  Fu Jun  Zhao Ke  Chen Baojun
Affiliation:1. Department of Thoracic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China
Abstract:Objective To investigate the correlation between thymic epithelial tumors and the systemic immune-inflammation index based on histological classification of World Health Organization.Methods From January 2017 to December 2019,46 cases of thymic epithelial tumors confirmed by operation and pathology were analyzed retrospectively.According to the histological classification of WHO published in 2015,data were divided into low risk thymoma(LRT including type A,AB and B1),high risk thymoma(HRT including type B2 and B3),thymic carcinoma(TC).Patients of benign thymic tumor(BTT)treated by operation at the same time were reviewed as a control group.For all patients,their peripheral blood platelet(P),neutrophil(N),and lymphocyte(L)counts were obtained 4 days before the operation.Indexes were calculated according to SII=P×N/L.The differences between the groups were compared,and the correlation with the degree of malignancy was calculated.Results A total of 46 patients with thymic epithelial tumors(20 in the low-risk group,19 in the high-risk group and 7 in the thymic cancer group)and 34 patients in the control group were included in the research.The SII value of the TC group was significantly higher than the other three groups,P=0.009.SII was significantly correlated with the malignancy of thymic epithelial tumors,with a correlation coefficient of 0.244(P=0.032).Conclusions Based on the histological classification of WHO,the malignant degree of thymic epithelial tumor is significantly correlated with the systemic immune-inflammatory index.SII can be used to clinically predict the malignancy of thymic epithelial tumors.
Keywords:Thymic epithelial tumor  Histological classification of WHO  Systemic immune-inflammatory index
本文献已被 维普 等数据库收录!
点击此处可从《中华胸部外科电子杂志》浏览原始摘要信息
点击此处可从《中华胸部外科电子杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号